MAIA Biotechnology (MAIA) Earnings Date & Reports

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of targeted immunotherapies for cancer, with an initial focus on non-small cell lung cancer (NSCLC), which represents the majority of lung cancer cases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

MAIA is expected to report earnings to fall 7.69% to -11 cents per share on November 10

MAIA Biotechnology MAIA Stock Earnings Reports

Q3'26

Est.

$-0.12

Q2'26

Beat

by $0.09

Q1'26

Beat

by $0.02

Q4'25

Beat

by $0.03

Q3'25

Missed

by $0.08

The last earnings report on August 24 showed earnings per share of -12 cents, beating the estimate of -21 cents. With 379.84K shares outstanding, the current market capitalization sits at 84.55M.

View a ticker or compare two or three

MAIA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days